hrp0082p3-d1-958 | Sex Development | ESPE2014

17βHSD-3 Enzyme Deficiency in Newborn Due to a Novel Mutation in HSD17B3 Gene

Sagsak Elif , Aycan Zehra , Erdeve Senay Savas , Keskin Meliksah , Cetinkaya Semra , Karaer Kadri

Background: 17β-Hydroxysteroid dehyrogenase type 3 (17βHSD-3) deficiency is an autosomal recessive form of 46,XY disorder of sex development (DSD). 17βHSD-3 is present almost exclusively in the testes and converts androstenedione to testosterone. The diagnosis can be easily missed in early childhood as the clinical presentation may be subtle. The most frequent presentation of 17βHSD-3 deficiency is a 46,XY individual with female external genitalia, labial f...

hrp0082p3-d2-994 | Thyroid (1) | ESPE2014

The Evaluation of Transient Hypothyroidism in Patients Diagnosed with Congenital Hypothyroidism

Kendirci Havva Nur Peltek , Aycan Zehra , Sagsak Elif , Keskin Meliksah , Cetinkaya Semra

Background: Congenital hypothyroidism (CH) is divided into two main groups as ‘permanent’ and ‘transient’. Diagnosis of transient hypothyroidism is important to avoid lifelong unnecessary therapy with its possible side effects.Objective and hypotheses: We aimed to determine the rate of transient and permanent congenital hypothyroidism of the newborns referred to our clinic from the neonatal screening program in this study.</st...

hrp0084p3-999 | Gonads | ESPE2015

Sertoli Cell Tumour in a Case of Androgen Insensitivity Syndrome

Erdeve Senay Savas , Aycan Zehra , Keskin Meliksah , Cetinkaya Semra , Karaman Ayse , Apaydin Sema , Cakmakci Emin

Introduction: Complete androgen insensitivity syndrome (CAIS) is a sexual development disorder due to mutations that cause function loss in androgen receptors in 46, XY individuals. The risk of malignancy development until the age of 25 years in CAIS is 5–10%. We present a CAIS case where a Sertoli cell tumour was found, together with the USG and MR findings.Case: A 17-year-old female presented to our department complaining of amenorrhoea. She had a...

hrp0094p2-315 | Growth and syndromes (to include Turner syndrome) | ESPE2021

Characteristics of Patients with Noonan Syndrome Carrying a PTPN11 Mutation: The Recombinant Growth Hormone Treatment and Long-Term Follow-up

Karacan Kucukali Gulin , Okur Iclal , Erdeve Senay Savas , Muratoglu Sahin Nursel , Keskin Meliksah , Cetinkaya Semra ,

Introduction: Noonan Syndrome (NS) is a heterogeneous group of diseases with a genetic etiology affecting the RAS/MAPK signaling pathway known as RASopathy. Genes known to cause NS are PTPN11, KRAS, SOS1, RAF1, BRAF, SHOC2 and RIT1. There are sufficient studies indicating that recombinant growth hormone (rhGH) therapy can be given without increasing risk of developing cancer in NS cases with PTPN11 mutations from different centers. In this study, it was aimed ...

hrp0094p2-355 | Pituitary, neuroendocrinology and puberty | ESPE2021

Did Central Precocious Puberty Increase in COVID 19 Pandemic?

Orman Burce , Esen Senem , Keskin Meliksah , Sahin Nursel Muratoglu , Savas Erdeve Senay , Cetinkaya Semra ,

Background: The timing of puberty in children is occurring at an increasingly early age. During the COVID19 pandemic period, children experienced changes such as epidemic stress, sedentary life, and weight gain.Aim: To make a retrospective evaluation of the incidence of newly diagnosed central precocious puberty (CPP) during the first months of COVID-19. And to compare these corresponding data with the previousy ear....

hrp0089p1-p242 | Sex Differentiation, Gonads and Gynaecology or Sex Endocrinology P1 | ESPE2018

AMH Level of Infants with Premature Thelarche and Possible Relationship between AMH and Mini-puberty

Sahin Nursel Muratoglu , Bayramoglu Elvan , Ozcan Hatice Nursun , Kurnaz Erdal , Keskin Meliksah , Erdeve Senay Savas , Cetinkaya Semra , Aycan Zehra

Background/aims: AMH levels of mini puberty are higher than prepubertal period. In this study we investigated AMH levels in infants with premature thelarche who are presumed to have exaggerated mini puberty due to inadequate/late suppression of pubertal activation.Methods: Fifty five female infants between 3 months and 3 years of age with premature thelarche were enrolled in the study and 49 healthy girls in the same age group were included in the study....

hrp0086p1-p137 | Bone &amp; Mineral Metabolism P1 | ESPE2016

Treatment Experience and Long-Term Follow-Up Data in Two Severe Neonatal Hyperparathyroidism Cases

Savas-Erdeve Senay , Sagsak Elif , Keskin Meliksah , Magdelaine Corinne , Lienhardt-Roussie Anne , Kurnaz Erdal , Cetinkaya Semra , Aycan Zehra

Background: Inactivating mutations in the calcium sensing receptor (CASR) may result in disorders of calcium homeostasis manifesting as familial benign hypocalciuric hypercalcemia (FBHH) and neonatal severe hyperparathyroidsm (NSHPT).Objective and hypotheses: We report two cases with NSHPT together with their treatment and long-term follow-up.Method: Two cases were referred with severe hypercalcemia in the neonatal period....

hrp0084p2-200 | Adrenals | ESPE2015

A Novel Mutation (c.delG209) in the Proopiomelanocortin Gene in a Child with Early-onset Obesity

Cetinkaya Semra , Guran Tulay , Kurnaz Erdal , Keskin Meliksah , Sagsak Elif , Erdeve Senay Savas , Buonocore Federica , Aycan Zehra

Background: Proopiomelanocortin (POMC) deficiency is characterized by early-onset obesity, adrenal failure, red hair and pale skin. The first genetic mutation in the POMC gene was demonstrated in 1998. This disorder is rare, but has increased our insight into the important role of the leptin-melanocortin pathway in energy balance. POMC deficiency causes obesity due to the inadequate production of alpha and beta MSH from POMC, which normally activate the melanocortin 3 receptor...

hrp0094p2-242 | Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) | ESPE2021

Long-term follow-up in a case with congenital hyperinsulinemic hypoglycemia with a novel p.Ser1389Pro mutation in ABCC8 gene

Karacan Kucukali Gulin , Karacan Kucukali Gulin , Savas Erdeve Senay , Ozalkak Servan , Bayramoglu Elvan , Keskin Meliksah , Aycan Zehra , Cetinkaya Semra ,

Introduction: Hyperinsulinemic hypoglycemia is one of the most common causes of severe and persistent hypoglycemia in neonates and children. Early diagnosis and appropriate treatment prevent brain damage due to recurrent hypoglycemia. Genetic examination often can guide the treatment. The most common affected genes are the ABCC8 and KCNJ11 genes, which encode the SUR1 and Kir6.2 KATP channels, respectively. Here, a neonate with a novel variant in AB...

hrp0098p3-124 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2024

Cause of Hypoglycemia in a Case with Turner Syndrome: Hyperinsulinemic Hypoglycemia

Arasli Yilmaz Aslihan , Şeyma Eken Emine , Kurnaz Erdal , Keskin Meliksah , Aslı Bala Keziban , Savas Erdeve Senay

Introduction: Hyperinsulinemic hypoglycemia (HH) is a clinically, genetically and morphologically heterogeneous group of diseases characterized by dysregulation of insulin secretion by pancreatic beta cells. HH may be associated with congenital, genetic, metabolic or syndromic causes. Here, a case in which Turner Syndrome (TS) and hyperinsulinemic hypoglycemia were detected together is presented due to its rarity.Case: A...